Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
Enoxaparin Sodium Injection, USP is used for prophylaxis of Deep Vein Thrombosis (DVT) in patients undergoing abdominal, hip or knee replacement surgery, and also for the treatment of acute DVT
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
Subscribe To Our Newsletter & Stay Updated
